Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prothena Corporation PLC (NASDAQ:PRTA)

62.54
Delayed Data
As of Sep 23
 -1.06 / -1.67%
Today’s Change
28.20
Today|||52-Week Range
76.42
-8.18%
Year-to-Date
No recent news for Prothena Corporation PLC.

Today’s Trading

Previous close63.60
Today’s open62.82
Day’s range62.08 - 64.50
Volume247,957
Average volume (3 months)438,977
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-817.24%
Earnings growth (this year)-57.07%
Earnings growth (next 5 years)-134.72%
Revenue growth (last year)-96.84%
P/E ratioNM
Price/Sales1,285.33
Price/Book5.50

Competitors

 Today’s
change
Today’s
% change
AGIOAgios Pharmaceutical...0.000.00%
PBYIPuma Biotechnology I...+2.10+3.18%
OPHTOphthotech Corp-0.84-1.42%
IRWDIronwood Pharmaceuti...-0.15-0.95%
Data as of 4:01pm ET, 09/23/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$1.17
Annual revenue (last year)$1.6M
Annual profit (last year)-$80.6M
Net profit margin-5,016.30%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Dale B. Schenk
Chief Operating &
Scientific Officer
Gene G. Kinney
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts

Search for Jobs